Emerging immunotherapies in older adults with acute myeloid leukemia

por Vasu, Sumithira, Blum, William
Publicado 2013

Targeted immunotherapy for acute myeloid leukemia

por Vasu, Sumithira, Caligiuri, Michael A.
Publicado 2011

The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60 years

por Wall, Sarah A., Devine, Steven, Vasu, Sumithira
Publicado en Blood Rev (2017)

Discharge disposition following hematopoietic cell transplantation: Predicting need for rehabilitation and association with survival

por Wall, Sarah A., Zhao, Qiuhong, Vasu, Sumithira, Rosko, Ashley
Publicado en Transplant Cell Ther (2020)

A Novel Method to Expand Large Numbers of CD56(+)Natural Killer Cells from a Minute Fraction of Selectively Accessed Cryopreserved Cord Blood for Immunotherapy Post-transplantation

por Vasu, Sumithira, Berg, Maria, Davidson-Moncada, Jan, Tian, Xin, Cullis, Herb, Childs, Richard W.
Publicado en Cytotherapy (2015)

Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia

por Patel, Sandipkumar H., Vasu, Sumithira, Guo, Ling, Lemaster, Olivia, Byrd, John C., Walker, Alison
Publicado en J Natl Compr Canc Netw (2020)

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse

por Kent, Andrew, Vasu, Sumithira, Schatz, Derek, Monson, Natalie, Devine, Steven, Smith, Clayton, Gutman, Jonathan A., Pollyea, Daniel A.
Publicado en Blood Adv (2020)

Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia

por Mani, Rajeswaran, Rajgolikar, Girish, Nunes, Jessica, Zapolnik, Kevan, Wasmuth, Ronni, Mo, Xiaokui, Byrd, John C., Lee, Dean A., Muthusamy, Natarajan, Vasu, Sumithira
Publicado en Cytotherapy (2020)

FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome

por He, Shun, Chu, Jianhong, Vasu, Sumithira, Deng, Youcai, Yuan, Shunzong, Zhang, Jianying, Fan, Zhijin, Hofmeister, Craig C., He, Xiaoming, Marsh, Henry C., Devine, Steven M., Yu, Jianhua
Publicado 2013

Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types

por Kulkarni, Amit A, Ebadi, Maryam, Zhang, Shijia, Meybodi, Mohamad A, Ali, Alaa M, DeFor, Todd, Shanley, Ryan, Weisdorf, Daniel, Ryan, Charles, Vasu, Sumithira, Rashidi, Armin, Patel, Manish Ramesh
Publicado en ESMO Open (2020)

Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

por Pantin, Jeremy, Tian, Xin, Geller, Nancy, Ramos, Catalina, Cook, Lisa, Cho, Elena, Scheinberg, Phillip, Vasu, Sumithira, Khuu, Hahn, Stroncek, David, Barrett, John, Young, Neal S., Donohue, Theresa, Childs, Richard W.
Publicado 2014

Midostaurin, Bortezomib and MEC in Relapsed/Refractory Acute Myeloid Leukemia

por Walker, Alison R., Wang, Hongyan, Walsh, Katherine, Bhatnagar, Bhavana, Vasu, Sumithira, Garzon, Ramiro, Canning, Renee, Geyer, Susan, Wu, Yue-Zhong, Devine, Steven M., Klisovic, Rebecca, Blum, William, Marcucci, Guido
Publicado en Leuk Lymphoma (2016)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado 2014

Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem...

por Salem, Galena, Ruppert, Amy S., Elder, Patrick, Hofmeister, Craig C., Benson, Don M., Penza, Sam, Andritsos, Leslie, Klisovic, Rebecca, Vasu, Sumithira, Blum, William, Devine, Steven M, Jaglowski, Samantha, Efebera, Yvonne A.
Publicado en Leuk Lymphoma (2014)

Activation of the intracellular pattern-recognition receptor NOD2 promotes acute myeloid leukemia cell apoptosis and provides a survival advantage in an animal model of AML

por Buteyn, Nathaniel J., Santhanam, Ramasamy, Merchand-Reyes, Giovanna, Murugesan, Rakesh A., Dettorre, Gino M., Byrd, John C., Sarkar, Anasuya, Vasu, Sumithira, Mundy-Bosse, Bethany L., Butchar, Jonathan P., Tridandapani, Susheela
Publicado en J Immunol (2020)

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia

por Gopalakrishnan, Bhavani, Cheney, Carolyn, Mani, Rajeswaran, Mo, Xiaokui, Bucci, Donna, Walker, Alison, Klisovic, Rebecca, Bhatnagar, Bhavana, Walsh, Katherine, Rueter, Bjoern, Waizenegger, Irene C., Heider, Karl-Heinz, Blum, William, Vasu, Sumithira, Muthusamy, Natarajan
Publicado en Oncotarget (2018)

Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

por Ranganathan, Parvathi, Yu, Xueyan, Santhanam, Ramasamy, Hofstetter, Jessica, Walker, Alison, Walsh, Katherine, Bhatnagar, Bhavana, Klisovic, Rebecca, Vasu, Sumithira, Phelps, Mitch A., Devine, Steven, Shacham, Sharon, Kauffman, Michael, Marcucci, Guido, Blum, William, Garzon, Ramiro
Publicado en Blood (2015)

A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acut...

por Vij, Ravi, Le-Rademacher, Jennifer, Laumann, Kristina, Hars, Vera, Owzar, Kouros, Shore, Tsiporah, Vasu, Sumithira, Cashen, Amanda, Isola, Luis, Shea, Thomas, DeMagalhaes-Silverman, Margarida, Hurd, David, Meehan, Kenneth, Beardell, Frank, Devine, Steven
Publicado en Biol Blood Marrow Transplant (2019)

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

por Jeon, Jae Yoon, Zhao, Qiuhong, Buelow, Daelynn R., Phelps, Mitch, Walker, Alison R., Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory, Blachly, James, Blum, William, Klisovic, Rebecca B., Byrd, John C., Garzon, Ramiro, Baker, Sharyn D., Bhatnagar, Bhavana
Publicado en Invest New Drugs (2019)

Selinexor in Combination with Decitabine in Patients with Acute Myeloid Leukemia: Results from a Phase 1 study

por Bhatnagar, Bhavana, Zhao, Qiuhong, Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory K., Larkin, Karilyn, Blachly, James S., Blum, William, Klisovic, Rebecca B., Ruppert, Amy S., Orwick, Shelley, Oakes, Christopher, Ranganathan, Parvathi, Byrd, John C., Walker, Alison R., Garzon, Ramiro
Publicado en Leuk Lymphoma (2019)